Inactief instrument

Koers Urologix, Inc. Other OTC

Aandelen

Duur

Periode

Stijl

Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015	12-05-15
Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015	05-02-15
Transcript : Urologix, Inc., Q1 2015 Earnings Call, Nov 04, 2014	04-11-14
Transcript : Urologix, Inc., Q4 2014 Earnings Call, Aug 19, 2014	19-08-14
Transcript : Urologix, Inc., Q3 2014 Earnings Call, May 06, 2014	06-05-14
Transcript : Urologix, Inc., Q2 2014 Earnings Call, Feb 04, 2014	04-02-14
Transcript : Urologix, Inc., Q1 2014 Earnings Call, Oct 29, 2013	29-10-13
Transcript : Urologix, Inc., Q4 2013 Earnings Call, Aug 20, 2013	20-08-13
Transcript : Urologix, Inc., Q3 2013 Earnings Call, May 01, 2013	01-05-13
Transcript : Urologix, Inc., Q2 2013 Earnings Call, Feb 05, 2013	05-02-13
Transcript : Urologix, Inc., Q1 2013 Earnings Call, Nov 14, 2012	14-11-12
Transcript : Urologix, Inc., Q4 2012 Earnings Call, Aug 23, 2012	23-08-12
Transcript : Urologix, Inc., Q3 2012 Earnings Call, Apr 26, 2012	26-04-12

A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	02-02-16
Urologix Conducting A Strategic Review	09-07-15
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015	12-05-15
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015	23-03-15
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014	05-02-15

Managers	Titel	Leeftijd	Van
Mitchell Dann FOU	Founder	63	29-05-91
Scott Madson DFI	Director of Finance/CFO	63	01-04-15
Lisa Ackermann SAM	Sales & Marketing	51	16-06-11

Besturend	Titel	Leeftijd	Van
Mitchell Dann FOU	Founder	63	29-05-91
Sidney Emery BRD	Director/Board Member	74	01-10-05
Christopher Barys BRD	Director/Board Member	57	06-08-10

21st North Inc. houdt zich niet bezig met bedrijfsactiviteiten. Het bedrijf is ontbonden.

Sector

	Vaira. 1 jan.	Kapi.
THERMO FISHER SCIENTIFIC	+7,77%	218 mld.
DANAHER CORPORATION	+10,16%	189 mld.
INTUITIVE SURGICAL, INC.	+26,21%	151 mld.
BOSTON SCIENTIFIC CORPORATION	+32,78%	113 mld.
SIEMENS HEALTHINEERS AG	+1,98%	64,02 mld.
EDWARDS LIFESCIENCES CORPORATION	+14,48%	52,6 mld.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2,92%	49,85 mld.
AGILENT TECHNOLOGIES, INC.	-6,60%	37,89 mld.
GE HEALTHCARE TECHNOLOGIES INC.	-1,07%	34,92 mld.